Advertisement

Topics

Genea Stem Cells Pty Ltd Company Profile

05:27 EST 14th December 2018 | BioPortfolio

Genea Biocells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Biocells Pty Ltd is governed by the same strong ethical principles and corporate governance practices.

Genea Biocells is located in Sydney, Australia and has been supplying commercial stem cell solutions for several years, drawing on an almost 30 year research heritage within Genea.

Genea Biocells supplies and develops disease-specific pluripotent and differentiated human stem cells for use in drug development and research. Our Company’s cellular products are human cells - the most accurate in vitro reflection of clinical conditions, promising more predictive disease models and thereby reducing the need for animal studies. GBC provides the following products for use in drug development and medical research:

  • The world’s largest private bank of pluripotent human embryonic stem cells. More than 100 cell lines representing almost 30 genetic diseases in a variety of genetic backgrounds. Cell lines include human embryonic stem cells (hESC) and genetically modified cell lines upon specific request.
  • The world’s only commercially-available, application-ready differentiated disease specific cell types (available from any GBC stem cell line).
  • Building on extensive expertise in stem cell differentiation and design of stem cell assays, Genea Biocells offers contract research services to generate customised solutions for drug development using pluripotent or differentiated human cells.
  • A unique specialised stem cell medium (Genea M2) – serum-free, fully-defined and applicable for high throughput screening applications.

Human embryonic stem cell lines available at Genea Biocells are derived from excess ART embryos and those unsuitable for further clinical use. These embryos are excess to the clinical requirements of Genea patients and have been specifically donated for stem cell derivation. Embryo donation for research purposes is subject to strict ethical and regulatory mechanisms. Consent is voluntary, fully informed and offered to couples as an alternative to discard of excess embryos.

Location

Level 3, 321 Kent Street
Sydney
New South Wales
2000
Australia

Contact

Phone: +61 2 8484 7662
Fax: +61 2 9229 6478
Email: +61 2 9229 6478


News Articles [2127 Associated News Articles listed on BioPortfolio]

New combination treatment targets pre-leukaemia stem cells

Your body's blood cells are manufactured by hematopoietic stem cells in bone marrow. But just as regular, mature cells can become cancerous, so too can stem cells. When hematopoietic stem cells mutat...

Drug combination targets pre-leukemia stem cells

Your body's blood cells are manufactured by hematopoietic stem cells in bone marrow. But just as regular, mature cells can become cancerous, so too can stem cells.

Human skeletal stem cells identified

Human skeletal stem cells that become bone, cartilage, or stroma cells have been isolated from fetal and adult bones. This is the first time that skeletal stem cells, which had been observed in rodent...

Family tree of blood production reveals hundreds of thousands of stem cells

Adult humans have ten times more blood-creating stem cells in their bone marrow than previously thought, ranging between 50,000 and 200,000 stem cells. Researchers developed a new approach for studyin...

The Future of Cord Blood and Perinatal Stem Cells

The stem cells found in umbilical cord blood are hematopoietic stem cells (HSCs), which can help in the replenishment of a depleted blood supply by providing new, healthy cells in the case of certain ...

Medical News Today: What are stem cells, and what do they do?

Stem cells are basic cells that can become almost any type of cell in the body. Human stem cells can come from an embryo or an adult human. They have many possible uses in science and medicine, yet co...

Orphan status given to Genea's facioscapulohumeral muscular dystrophy drug

Genea Biocells' GBC0905, being developed as a treatment for patients with facioscapulohumeral muscular dystrophy, has been gi -More- 

Mechanism for Turning Skin Cells into Blood Stem Cells Uncovered

(PhysOrg) – Researchers have succeeded in converting human skin cells into blood stem cells in an international collaboration project. “This is a first step on the way to generating fully ...

PubMed Articles [5454 Associated PubMed Articles listed on BioPortfolio]

Advances in perinatal stem cells research: a precious cell source for clinical applications.

Perinatal tissues possess numerous types of stem (stromal) cells, which are considered effective candidates for cell therapy. These tissues possess common characteristics of both embryonic and adult s...

Antiviral resistance of stem cells.

Stem cells are important for growth and regeneration given their ability to self-renew and differentiate into mature cells. Resistance to certain viral infections has been established as a phenotype o...

Application of Stem Cells to Infertility Treatment with Emphasis on Mesenchymal Stem Cells and Ovarian Stem Cells.

Stem cells are a population of undifferentiated cells that originated from embryonic and fetal stages of development. Stem cells possess the potency to produce cells that ultimately form different tis...

Two to Tango: Dialog between Immunity and Stem Cells in Health and Disease.

Stem cells regenerate tissues in homeostasis and under stress. By taking cues from their microenvironment or "niche," they smoothly transition between these states. Immune cells have surfaced as promi...

Muscling in on the Awesome Proliferative Power of the Terrible Teratoma.

In this issue of Cell Stem Cell, Chan et al. (2018) report that in vivo differentiation of pluripotent stem cells in induced teratomas produces functional embryonic-like muscle stem cells. These pur...

Clinical Trials [8426 Associated Clinical Trials listed on BioPortfolio]

Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis

This study is being done to test if it is safe to give stem cells to adult patients with Cystic Fibrosis (CF). The kind of stem cells we are studying are called allogeneic human mesenchyma...

Dysfunctions of Human Muscle Stem Cells in Sepsis

The dysfunction of muscle stem cells after sepsis is demonstrated in mice. It is also observed that mesenchymal stem cells have a positive effect on muscle stem cells in this animal model....

Thalassemia Treatment Based on the Stem Cell Technology

In order to study the transplantation effect of hematopoetic stem cells from beta-thalassemia induced pluripotent stem cells. We applied clinical grade source of autologous hematopoietic s...

HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection

This pilot phase I trial studies the side effects and best dose of human immunodeficiency virus (HIV)-resistant gene modified stem cells in treating HIV-positive patients who are undergoin...

Endocardial Stem Cells Approach Efficacy

The primary objective of this study is to test that endocardial stem cells implantation in patients who have CAD, low ejection fraction and signs of HF without possibility of CABG and PCI ...

Companies [823 Associated Companies listed on BioPortfolio]

Genea Stem Cells Pty Ltd

Genea Stem Cells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Stem Cells Pty ...

Genea Stem Cells Pty Ltd

Genea Biocells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Biocells Pty Ltd ...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

Cellerant Therapeutics, Inc.

Embryonic Stem Cells are derived from early-stage embryos before mature organs and tissues have developed. Embryonic stem cells have the greatest potential for both self-renewal (creating large number...

Forever Labs

Forever Labs is the first company to bank young adult stem cells, so you can live a healthier and longer life. Research on stem cells suggest that as you age, you lose stem cells ...

More Information about "Genea Stem Cells Pty Ltd" on BioPortfolio

We have published hundreds of Genea Stem Cells Pty Ltd news stories on BioPortfolio along with dozens of Genea Stem Cells Pty Ltd Clinical Trials and PubMed Articles about Genea Stem Cells Pty Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genea Stem Cells Pty Ltd Companies in our database. You can also find out about relevant Genea Stem Cells Pty Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record